31.10 Challenges faced by gene therapy
- • Immune rejection of the foreign protein, plasmid and DNA by the target cells.
• Localization of the desired gene product.
• Insertional mutagenesis risk due to use of viral vectors since the viral vector genome may integrate with the host genome.
Figure 31.2 Supplementary diagram of ribozyme mediated trans-splicing:
